4β-Hydroxycholesterol as an endogenous biomarker for CYP3A induction: Scientific rationale, clinical utility, and future perspectives

Drug Metabolism and Pharmacokinetics 2026

View at publisher

Authors: Barry Jones

DOI: 10.1016/j.dmpk.2026.101524

Cited by: 2

References: 47

Fields of Study & Subjects

Pharmacogenetics and Drug Metabolism Cholesterol and Lipid Metabolism Hormonal Regulation and Hypertension

References 47